Skip to main navigation Skip to search Skip to main content

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells

  • Robin E. Bachelder
  • , Aimee Crago
  • , Jun Chung
  • , Melissa A. Wendt
  • , Leslie M. Shaw
  • , Arthur M. Mercurio
  • Harvard University
  • Boston Children's Hospital

Research output: Contribution to journalArticlepeer-review

420 Scopus citations

Abstract

We identify a novel function for the vascular endothelial growth factor (VEGF) in its ability to stimulate an autocrine signaling pathway in metastatic breast carcinoma cells that is essential for their survival. Suppression of VEGF expression in metastatic cells in vitro induced their apoptosis, in addition to inhibiting the constitutively elevated phosphatidylinositol 3′-kinase activity that is characteristic of these cells and important for their survival. Hypoxia enhanced the survival of metastatic cells by increasing VEGF expression. The importance of the VEGF receptor neuropilin was indicated by the ability of a neuropilin-binding VEGF isoform to enhance breast carcinoma survival. Moreover, the expression of neuropilin in neuropilin-deficient breast carcinoma cells protected them from apoptosis. The identification of this VEGF autocrine signaling pathway has important implications for tumor metastasis and therapeutic intervention.

Original languageEnglish
Pages (from-to)5736-5740
Number of pages5
JournalCancer Research
Volume61
Issue number15
StatePublished - Aug 1 2001

Fingerprint

Dive into the research topics of 'Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells'. Together they form a unique fingerprint.

Cite this